This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2014 Jun;39(11):1337-8.

doi: 10.1111/apt.12702.

Letter: Response-guided treatment of hepatitis C virus genotype 5 may be feasible

V Papastergiou¹, S Karatapanis

Affiliations

PMID: 24803251
DOI: 10.1111/apt.12702

Comment

Letter: Response-guided treatment of hepatitis C virus genotype 5 may be feasible

V Papastergiou et al. Aliment Pharmacol Ther. 2014 Jun.

. 2014 Jun;39(11):1337-8.

doi: 10.1111/apt.12702.

Authors

V Papastergiou¹, S Karatapanis

Affiliation

¹ First Department of Internal Medicine, General Hospital of Rhodes, Rhodes, Greece. vasi.pap@hotmail.com.

PMID: 24803251
DOI: 10.1111/apt.12702

No abstract available

PubMed Disclaimer

Comment in

Letter: Response-guided treatment of hepatitis C virus genotype 5 may be feasible--authors' reply.
Wantuck JM, Nguyen MH. Wantuck JM, et al. Aliment Pharmacol Ther. 2014 Jun;39(11):1338. doi: 10.1111/apt.12747. Aliment Pharmacol Ther. 2014. PMID: 24803252 No abstract available.

Comment on

Review article: the epidemiology and therapy of chronic hepatitis C genotypes 4, 5 and 6.
Wantuck JM, Ahmed A, Nguyen MH. Wantuck JM, et al. Aliment Pharmacol Ther. 2014 Jan;39(2):137-47. doi: 10.1111/apt.12551. Epub 2013 Nov 19. Aliment Pharmacol Ther. 2014. PMID: 24251930 Review.

Similar articles

Letter: Response-guided treatment of hepatitis C virus genotype 5 may be feasible--authors' reply.
Wantuck JM, Nguyen MH. Wantuck JM, et al. Aliment Pharmacol Ther. 2014 Jun;39(11):1338. doi: 10.1111/apt.12747. Aliment Pharmacol Ther. 2014. PMID: 24803252 No abstract available.
Letter: chronic hepatitis C genotype 3 infection - still a hurdle toward a direct-acting anti-viral-induced HCV cure?
Bruno G, Milella M, Angarano G, Saracino A. Bruno G, et al. Aliment Pharmacol Ther. 2017 May;45(10):1376-1377. doi: 10.1111/apt.14042. Aliment Pharmacol Ther. 2017. PMID: 28417495 No abstract available.
[Recommendations for the treatment of chronic genotype 1 hepatitis C virus infection].
Silva MO, Ridruejo E, Galdame O, Bessone F, Colombato L, Daruich J, Fainboim H, Fassio E, Fay F, Frider B, Gadano A, Galoppo MC, González J, Tanno H, Terg R, Villamil F; Comisión de Expertos en Hepatitis Virales de la Asociaci6n Argentina para el Estudio de las Enfermedades; del Hígado. Silva MO, et al. Acta Gastroenterol Latinoam. 2012 Sep;42(3):234-49. Acta Gastroenterol Latinoam. 2012. PMID: 23214356 Spanish. No abstract available.
Chronic hepatitis C: genotypes 4 to 9.
Nguyen MH, Keeffe EB. Nguyen MH, et al. Clin Liver Dis. 2005 Aug;9(3):411-26, vi. doi: 10.1016/j.cld.2005.05.010. Clin Liver Dis. 2005. PMID: 16023974 Review.
Hepatitis C Virus: Current and Evolving Treatments for Genotypes 2 and 3.
Ampuero J, Romero-Gómez M. Ampuero J, et al. Gastroenterol Clin North Am. 2015 Dec;44(4):845-57. doi: 10.1016/j.gtc.2015.07.009. Epub 2015 Aug 11. Gastroenterol Clin North Am. 2015. PMID: 26600223 Review.

See all similar articles

Cited by

Current status and emerging challenges in the treatment of hepatitis C virus genotypes 4 to 6.
Papastergiou V, Karatapanis S. Papastergiou V, et al. World J Clin Cases. 2015 Mar 16;3(3):210-20. doi: 10.12998/wjcc.v3.i3.210. World J Clin Cases. 2015. PMID: 25789294 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations